New hope for elderly brain cancer patients when standard chemo fails
NCT ID NCT07476794
Summary
This study is testing a different way of giving a common chemotherapy drug (temozolomide) to elderly patients with a specific, hard-to-treat type of brain cancer called glioblastoma. The goal is to see if giving the drug on a modified schedule can help slow the cancer's growth and help patients live longer. The study is for patients aged 65+ whose tumors have a genetic marker that makes them less likely to respond to the standard chemotherapy treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N3M5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.